Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)

Clinical Infectious Diseases

Volumn 33, Issue 4, 2001, Pages 492-502

  Dowell, Scott F ^a   Peeling, Rosanna W ^d   Boman, Jens ^e   Carlone, George M ^a   Fields, Barry S ^a   Guarner, Jeannette ^a   Hammerschlag, Margaret R ^c   Jackson, Lisa A ^b   Kuo, Cho Chou ^b   Maass, Matthias ^f   Messmer, Trudy O ^a   Talkington, Deborah F ^a   Tondella, Maria Lucia ^a   Zaki, Sherif R ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d LAB CENTRE FOR DISEASE CONTROL   (Canada)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G;

ARTICLE; ATHEROSCLEROSIS; BACTERIUM CULTURE; CHLAMYDOPHILA PNEUMONIAE; GENE AMPLIFICATION; HEALTH CARE ORGANIZATION; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; STANDARDIZATION;

BACTERIOLOGICAL TECHNIQUES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL LABORATORY TECHNIQUES; CULTURE MEDIA; DNA, BACTERIAL; HEALTH PLANNING GUIDELINES; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; UNITED STATES;

EID: 0035882178     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322632     Document Type: Article

References (82)

1. The role of Chlamydia pneumoniae in atherosclerosis
2. Collaborative multidisciplinary workshop report: Detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae
3. Serology for Chlamydia pneumoniae (TWAR)
4. Chlamydia pneumoniae infections: Applications of laboratory methods
5. The genus-specific antigen of Chlamydia: Resemblance to the lipopolysaccharide of enteric bacteria
6. Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection
7. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci
8. Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results
9. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR
10. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate
11. Antibody response to Chlamydia pneumoniae infection in children with respiratory illness
12. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
13. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
14. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project
15. Chlamydia pneumoniae and atherosclerosis
16. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis
17. Mycoplasma contamination of Chlamydia pneumoniae isolates
18. Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma
19. Enhanced susceptibility of trypsinized HeLa cells to Chlamydia trachomatis infection
20. Growth in serum-free medium improves isolation of Chlamydia pneumoniae
21. Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations
22. Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time
23. A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA
24. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae
25. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
26. Chlamydia pneumoniae pneumonia in hospitalized patients: Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL
27. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
28. Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol
29. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR
30. Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA
31. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients
32. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
33. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
34. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
35. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
36. Evidence of Chlamydia pneumoniae infection obtained by the polymerase chain reaction (PCR) in patients with acute myocardial infarction and coronary heart disease
37. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
38. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
39. High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement
40. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease
41. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
42. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients
43. Detection of Chlamydia pneumoniae by polymerase chain reaction
44. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene
45. Touchdown enzyme time release PCR for detection and identification of Chlamydia tracomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes
46. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population
47. Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers
48. A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction
49. Development of a simplified polymerase chain reaction-enzyme immunoassay for the detection of Chlamydia pneumoniae
50. Application of a nested, multiplex PCR to psittacosis outbreaks
51. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis
52. Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults
53. Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay
54. Detection of microorganisms in vessel wall specimens of the abdominal aorta: Development of a PCR assay in the absence of a gold standard
55. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR)
56. Comparison of PCR protocols including positive controls for detection of Chlamydia pneumoniae in respiratory specimens
57. Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction
58. Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae
59. PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR
60. Construction of an internal control for the detection of Chlamydia pneumoniae by PCR
61. Detection of Chlamydia pneumoniae in arterial tissues
62. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
63. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
64. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction
65. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
66. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
67. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
68. Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases
69. Chlamydia pneumoniae in coronary plaques: Increased detection with acute coronary syndrome
70. Chlamydia pneumoniae in vascular tissue
71. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery
72. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
73. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
74. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
75. Murine models of Chlamydia pneumoniae infection and atherosclerosis
76. De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model
77. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis
78. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies
79. Experimental rabbit models of Chlamydia pneumoniae infection
80. Demonstration of Chlamydia pneumoniae in tissue by immunohistochemistry
81. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits
82. Chlamydia pneumoniae in abdominal aortic aneurysms: Abundance of membrane components in the absence of heat shock protein 60 and DNA